m+Medelevator.RU
← Поиск публикаций
Journal of gastroenterology · 2026

Clinical characteristics and outcomes of bacterial and viral gastrointestinal infection by pathogen: a large-scale observational study in United States.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Kitano Taito, Kitagawa Daisuke, Yoshida Sayaka

Аннотация

BACKGROUND: The evaluations of clinical characteristics and outcomes by specific gastrointestinal (GI) pathogen are critical. This study aimed to evaluate GI pathogen-specific clinical characteristics and outcomes using a large-scale database.

METHODS: This retrospective cohort study used a database (TriNetX) of multicenter electronic health records to evaluate clinical characteristics and outcomes of GI infection by 14 bacterial and viral pathogen groups. Evaluated clinical outcomes were all-cause 30-day ward admission, critical care admission and mortality.

RESULTS: The number of patients with GI infection by pathogen ranged from Vibrio (N = 373) to norovirus (N = 24,100). For all-cause 30-day mortality, norovirus had the higher mortality rate (1.7%) than other viruses, including 0.4% for rotavirus, 0.9% for adenovirus, 0.5% for astrovirus, and 0.5% for sapovirus. The comparative trends by pathogen were maintained for the all-cause 30-day critical care admission rate and hospitalization rate. The elderly had the highest mortality rate across investigated GI pathogens. For the critical care admission rate by age group, Shiga toxin-producing E. coli (7.2%) and norovirus (5.0%) had relatively high critical care admission rates in children <5 years.

CONCLUSION: Severe clinical outcomes following GI infection were not rare across investigated pathogens with the elderly having the highest mortality rate. A limitation of this study was that it assessed only all-cause outcome events. The study findings may guide future development and allocation of preventive and therapeutic interventions.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты